AB-PINACA

AB-PINACA is a synthetic cannabinoid with notable research applications. This comprehensive guide will give you all the information you need about AB-PINACA. We’ll cover its development, chemical properties, uses, effects, and recommended dosages.

Development and background

AB-PINACA, a synthetic cannabinoid, was developed as a research chemical in recent years to better understand the endocannabinoid systems and the potential therapeutic applications of synthesized cannabinoids. AB-PINACA, the developer of which is unknown, has attracted significant interest from researchers due to its unique pharmacological characteristics and structural similarity to other synthetic cannabinoids such as AB-FUBINACA. Inocybe Aeruginascens , Zheetos Strain , London Poud cake strain , Polka dot mushroom chocolate , HHC gummies , Gymnopilus aeruginosus .

AB-PINACA  is a compound that was first identified as a component of  synthetic cannabis products  in Japan in 2012.  It was originally developed by Pfizer in 2009 as an analgesic medication  ¹ . It acts as a  potent agonist at both CB1  (Ki = 2.87 nM, EC50 = 1.2 nM) and  CB2  (Ki = 0.88 nM, EC50 = 2.5 nM)   receptors  , fully replacing Δ9-THC  in rat discrimination studies, being 1.5 times more potent . However, deaths and hospitalizations have been reported in connection with this synthetic cannabinoid .

Regarding their  legal status :

• In  Germany , it has been a controlled substance under  Anlage II  since November 2014.
• In  Singapore , it is listed in the Fifth Schedule of the Drug Abuse Act and is therefore illegal since May 2015.
• In the  United States , it is a Schedule I controlled substance  .
• In  China , it has also been controlled since October 2015.
• In  France , it has been classified as a controlled substance since March 2017.

If you have any further questions or need more information, please don’t hesitate to ask.